BE803804A - Nouvelles methylthio-5 pyrimidines utilisables comme medicaments - Google Patents

Nouvelles methylthio-5 pyrimidines utilisables comme medicaments

Info

Publication number
BE803804A
BE803804A BE134752A BE134752A BE803804A BE 803804 A BE803804 A BE 803804A BE 134752 A BE134752 A BE 134752A BE 134752 A BE134752 A BE 134752A BE 803804 A BE803804 A BE 803804A
Authority
BE
Belgium
Prior art keywords
pyrimidines
methylthio
new
medicinal products
medicinal
Prior art date
Application number
BE134752A
Other languages
English (en)
Inventor
J-M Claverie
G Loiseau
G Mattioda
R Millischer
F Percheron
Original Assignee
Ugine Kuhlmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ugine Kuhlmann filed Critical Ugine Kuhlmann
Publication of BE803804A publication Critical patent/BE803804A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE134752A 1973-07-06 1973-08-20 Nouvelles methylthio-5 pyrimidines utilisables comme medicaments BE803804A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7324875A FR2244520B1 (fr) 1973-07-06 1973-07-06

Publications (1)

Publication Number Publication Date
BE803804A true BE803804A (fr) 1974-02-20

Family

ID=9122192

Family Applications (1)

Application Number Title Priority Date Filing Date
BE134752A BE803804A (fr) 1973-07-06 1973-08-20 Nouvelles methylthio-5 pyrimidines utilisables comme medicaments

Country Status (11)

Country Link
US (1) US3968214A (fr)
JP (1) JPS5025576A (fr)
BE (1) BE803804A (fr)
CH (1) CH581120A5 (fr)
DE (1) DE2342881A1 (fr)
ES (1) ES418114A1 (fr)
FR (1) FR2244520B1 (fr)
GB (1) GB1450211A (fr)
LU (1) LU68264A1 (fr)
NL (1) NL7312324A (fr)
NO (1) NO137387C (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
US4560402A (en) * 1979-08-15 1985-12-24 Ciba Geigy Corporation 2,4-Diamo-5-(alkylsulfinyl) or alkylsulphonyl)-6-halopyrimidines
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
DE3417264A1 (de) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen Neue 2,4-diamino-6-halogen-5-alkylthio-pyrimidine
US5002949A (en) * 1990-05-01 1991-03-26 American Home Products Corporation 5-substituted-6-aminopyrimidine derivatives
US7205320B2 (en) * 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
BR0313000A (pt) * 2002-07-19 2005-07-12 Memory Pharm Corp Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente
WO2004052862A1 (fr) 2002-12-10 2004-06-24 Ono Pharmaceutical Co., Ltd. Composes heterocycliques contenant de l'azote et leur utilisation medicale
AU2006257863A1 (en) * 2005-06-10 2006-12-21 F. Hoffmann-La Roche Ag Trisubstituted amines as phosphodiesterase 4 inhibitors
RU2008152195A (ru) 2006-06-15 2010-07-20 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) 2-анилино-4-(гетероциклил)аминопиримидины, как ингибиторы протеинкиназы с-альфа
AU2007257701A1 (en) 2006-06-15 2007-12-21 Boehringer Ingelheim International Gmbh 2-anilino-4-aminoalkyleneaminopyrimidines
WO2010003084A2 (fr) * 2008-07-02 2010-01-07 Memory Pharmaceuticals Corporation Inhibiteurs de la phosphodiestérase 4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817998A (en) * 1971-10-28 1974-06-18 Sandoz Ag 2-amino and substituted amino-4, 6-diamino-5-pyrimidinesulfonamides

Also Published As

Publication number Publication date
FR2244520A1 (fr) 1975-04-18
NO137387B (no) 1977-11-14
NO137387C (no) 1978-02-22
GB1450211A (en) 1976-09-22
NO326173L (fr) 1975-02-03
CH581120A5 (fr) 1976-10-29
ES418114A1 (es) 1976-03-16
JPS5025576A (fr) 1975-03-18
US3968214A (en) 1976-07-06
NL7312324A (nl) 1975-01-08
FR2244520B1 (fr) 1977-02-04
DE2342881A1 (de) 1975-01-30
LU68264A1 (fr) 1973-10-24

Similar Documents

Publication Publication Date Title
BE824359A (fr) Derives biphenyles utiles comme medicaments
FR2306697A1 (fr) Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
IL45492A0 (en) New pyrimidines,their preparation and pharmaceutical compositions containing them
BE836627A (fr) Nouvelle 3-cyano pyridines utiles comme medicaments
BE803804A (fr) Nouvelles methylthio-5 pyrimidines utilisables comme medicaments
FR2352808A1 (fr) Acides 12-azaprostanoiques utiles comme medicaments
BE865624A (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
NL7513538A (nl) Werkwijze voor de bereiding van nieuwe piperazine- verbindingen, en hun toepassing in geneesmiddelen.
FR2308361A1 (fr) Nouvelles 3,4-dihydrospiro-2h-1,3-benzoxazines utiles comme medicaments
SE7809907L (sv) Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar
BE824885A (fr) Nouvelles methylthio-5 pyrimidines utilisables comme medicaments antidiabetiques et hypochlolesterolemiants
BE803803A (fr) Nouvelles piperazino-pyrimidines utilisables comme medicaments
BE816214A (fr) Nouvelles compositions therapeutiques
BE825135A (fr) Derives de la benzofurannone utilisables comme medicaments
BE832277R (fr) Nouvelles piperazilo-pyrimidines utilisables comme medicaments
BE796114A (fr) Derive de pyrimidine utilisable comme medicament
NL7501430A (nl) Werkwijze voor het bereiden van aminodihydro- inen, werkwijze voor het bereiden van ge- iddelen alsmede gevormde geneesmiddelen.
BE816445A (fr) Derives bis-amines utiles comme medicaments
FR2315259A1 (fr) Nouvelles amidines terpenoaromatiques utilisables comme medicaments
SE7711779L (sv) Farmaceutiska kompositioner
FR2332017A1 (fr) Antibiotiques de type thienamycine utiles comme medicaments
BE861514A (fr) Derives de la piperazine utilisables comme medicaments
IL46181A0 (en) New quinoline derivatives,their manufacture and pharmaceutical compositions containing them
BE863007A (fr) Nouvelles arylenedioxy-bis-dicetones, leur preparation et leur utilisation comme medicaments
FR2322594A1 (fr) Nouvelles 2,3-trans-methylene-15-hydroxy-prostaglandines, leur preparation et leur application comme medicaments